Using nanoparticles to control immune responses

Polymeric nanoassemblies for precise tuning of immune responses

['FUNDING_OTHER'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-11076795

This study is exploring how tiny particles can help calm down the immune system to reduce harmful inflammation in people with autoimmune and allergic conditions, and it's designed for anyone looking for better ways to manage these health issues.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MARYLAND BALTIMORE (nih funded)
Locations1 site (BALTIMORE, UNITED STATES)
Trial IDNIH-11076795 on ClinicalTrials.gov

What this research studies

This research investigates how specially designed nanoparticles can influence the immune system to reduce harmful inflammation associated with various diseases. By creating nanoparticles with unique properties, the researchers aim to either dampen non-specific inflammatory responses or deliver specific antigens to immune cells, potentially leading to better management of autoimmune and allergic conditions. The approach involves testing these nanoparticles in laboratory models to assess their effectiveness in modulating immune responses and improving survival rates in severe inflammatory scenarios.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals suffering from autoimmune disorders, allergies, or other inflammatory conditions.

Not a fit: Patients with non-inflammatory conditions or those who do not have immune system-related issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that more effectively manage autoimmune and allergic diseases by precisely controlling immune responses.

How similar studies have performed: Previous research has shown promise in using nanoparticles for immune modulation, indicating that this approach could lead to significant advancements in treatment.

Where this research is happening

BALTIMORE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.